USPTO serial 79307749
IPONATIC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 14, 2021
- Examiner
- ONUOHA, UKACHUKWU FREDERICK
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with IPONATIC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Yue Robert Xu
Yue Robert Xu Apex Attorneys at Law, LLP160 Alamo Plaza #942Alamo, CA 94507UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Injectable pharmaceuticals for treatment of anaphylactic reactions; biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; antibiotic tablets; allergy tablets; mineral, vitamin, or nutritionally enhanced water for medical purposes; medicated water for the treatment of illnesses attributed to insufficient cellular energy; medicated water for the treatment of allergies, cough, cold, flu, headache, pain; medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal diseases and conditions; medicated water for the treatment of pain, nausea and muscle spasms; medicated water-based solutions for treating skin infections and skin conditions; medicated water for the treatment of gastrointestinal disorders; antibiotic ointments; anti-inflammatory ointments; medicated ointments for treating dermatological conditions; chinese medicine nostrum in the nature of natural remedy preparation, namely, medicinal herbs; diagnostic kits for medical diagnostic purposes comprising medical diagnostic reagents for use in disease testing, health monitoring and predictive and preventive medicine in the fields of detecting immune system and respiratory system diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; purified biochemicals, namely, protein arrays, enzymes, and fluorescent dyes for use as reagents in medical diagnostic applications; biological preparations for pharmaceutical purposes for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological, oncological, hematological, tissue and organ transplantation, ophthalmological and gastroenterological disorders; biochemical drugs for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological, oncological, hematological, tissue and organ transplantation, ophthalmological and gastroenterological disorders; chemical reagents for medical or veterinary purposes; reagents for medical use; medical diagnostic reagents for genetic testing; medical diagnostic reagents; enzyme preparations for medical purposes; diagnostic biomarker reagents for medical purposes; reagent paper for medical or veterinary purposes; diagnostic preparations for veterinary purposes; chemical preparations for the diagnosis of pregnancy; preparations for detecting genetic predispositions for medical purposes; immunoassay reagents for medical use; genetic identity tests comprised of reagents for medical purposes; preparations for detecting mutation in prion genes for medical purposes; cultures of microorganisms for medical or veterinary use | ACTIVE | — |
| 010 | Surgical apparatus and instruments; dropping pipettes for medical purposes; medical devices in the nature of a nucleic acid analyzer for medical diagnosis; diagnostic apparatus for medical and veterinary purposes, in particular for detecting target nucleic acid molecules in a sample, in particular in a patient sample; medical apparatus for purifying nucleic acids; medical nucleic acid amplification and detection apparatus; medical equipment, namely, devices for bioanalysis of pathogens incorporating cartridges for sample preparation, nucleic acid purification, nucleic acid amplification and electrochemical detection for medical diagnostic purposes; medical laboratory instruments for diagnostic use and medical diagnostic instruments, namely, nucleic acid sequencers and synthesizers, genetic analyzers, fragment analyzers, electrophoresis machines, linkage analyzers, genetic mappers, thermal cyclers, cytometer, chemical reaction mixture containment apparatus and structural parts thereof, protein and peptide synthesizers, mass spectrometer and chromatograph, high-throughput instruments for preparation of nucleic acid samples; X-ray diagnostic apparatus; X-ray apparatus for medical use; lasers for medical purposes; radiotherapy apparatus; physiotherapy apparatus, namely, body rehabilitation apparatus for medical use; orthopaedic belts; apparatus for use in medical analysis, namely, apparatus for blood analysis, body composition analyzers, apparatus for analyzing and detecting bacteria and viruses, apparatus for analyzing and detecting DNA and RNA, apparatus for analyzing and detecting genes, apparatus for analyzing blood vessels, apparatus for cavitation detecting, and apparatus for imaging analysis; diagnostic apparatus for medical purposes comprising diagnostic imaging apparatus, displays, monitors and recorded computer operating software therefor sold as a unit; digital hearing aids; analysers for bacterial identification for medical purposes; apparatus for DNA and RNA testing for medical purposes; blood testing apparatus | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sansure Biotech Inc.
- Other trademarks owned by Sansure Biotech Inc.
- Other trademarks owned by Sansure Biotech Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named IPONATIC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 28, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 2, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 2, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 14, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 14, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 28, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 28, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 8, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 22, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 19, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 18, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 18, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 12, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 19, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 19, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 15, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 14, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 8, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 6, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 1, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |